funder-graph › Recipients
Who funds Duke University School of Medicine
EIN 56-2247203
Duke University School of Medicine (EIN 56-2247203) was named as a grant recipient by 3 funders in 12 grants paid totaling $1,864,794 in tax years 2019–2025, as reported on the funders' Forms 990-PF and 990 Schedule I. Each edge was resolved to this EIN at the match tier shown. Dataset version 2026.09.0, built 2026-09-03.
Grants received
$1,864,794
12 grants paid
Funders
3
distinct grantmakers
Tax years
2019–2025
as reported by funders
Funders
| Funder | State | Match | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Alzheimer's Disease Research Foundation D/B/a Cure Alzheimer's Fund 52-2396428 | MA | A | 9 | $1,699,093 | 2025 |
| New Horizons Foundation Inc 84-1123082 | CO | A | 2 | $105,701 | 2024 |
| The Glaucoma Foundation Inc 13-3174839 | NY | A | 1 | $60,000 | 2020 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Grants
The 12 most recent grants naming this organization.
| Tax year | Funder | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|---|
| 2025 | Alzheimer's Disease Research Foundation | Duke University School of Medicine Durham, NC | A | $320,033 | paid | UTILITY OF BLOOD BASED MARKERS FOR PREDICTING ARIA AND ITS COURSE IN MCI AND AD SUBJECTS UNDERGOING ROUTINE CLINICAL TREATMENT WITH AMYLOID-DIRECTED ANTIBODIES | 202641319349301469 |
| 2025 | Alzheimer's Disease Research Foundation | Duke University School of Medicine Durham, NC | A | $204,656 | paid | CONTRIBUTIONS OF IL34 SIGNALING TO MICROGLIAL FUNCTION AND ALZHEIMER'S PATHOLOGY IN MICE | 202641319349301469 |
| 2024 | Alzheimer's Disease Research Foundation | Duke University School of Medicine Durham, NC | A | $268,750 | paid | PLASMA PROTEINS, SEX AND ALZHEIMER'S DIEASE: PROTEOMEWIDE ANALYSES OF THE UK BIOBANK AND FRAMINGHAM HEART STUDY | 202531289349302248 |
| 2024 | Alzheimer's Disease Research Foundation | Duke University School of Medicine Durham, NC | A | $192,314 | paid | CONTRIBUTIONS OF IL34 SIGNALING TO MICROGLIAL FUNCTION AND ALZHEIMER'S PATHOLOGY IN MICE | 202531289349302248 |
| 2024 | The New Horizons Foundation Inc | Duke Cancer Institute Durham, NC | A | $40,701 | paid | Program Support | 202503219349306440 |
| 2024 | Alzheimer's Disease Research Foundation | Duke University School of Medicine Durham, NC | A | $24,957 | paid | UTILITY OF BLOOD BASED MARKERS FOR PREDICTING ARIA AND ITS COURSE IN MCI AND AD SUBJECTS UNDERGOING ROUTINE CLINICAL TREATMENT WITH AMYLOID-DIRECTED ANTIBODIES | 202531289349302248 |
| 2022 | Alzheimer's Disease Research Foundation D/B/a Cure Alzheimer's Fund | Duke Durham, NC | A | $199,162 | paid | SEX DIFFERENCES IN ALZHEIMER'S DISEASE PROGRESSION: FRAMINGHAM HEART STUDY | 202331259349301933 |
| 2022 | Alzheimer's Disease Research Foundation D/B/a Cure Alzheimer's Fund | Duke Durham, NC | A | $194,253 | paid | CONTRIBUTIONS OF IL34 SIGNALING TO MICROGLIAL FUNCTION AND ALZHEIMERS PATHOLOGY IN MICE | 202331259349301933 |
| 2022 | New Horizons Foundation Inc | Duke Cancer Institute Durham, NC | A | $65,000 | paid | PROGRAM SUPPORT | 202343199349318709 |
| 2020 | Alzheimer's Disease Research Foundation D/B/a Cure Alzheimer's Fund | Duke University School of Medicine Durham, NC | A | $203,281 | paid | SEX DIFFERENCES IN ALZHEIMER'S DISEASE PROGRESSION: FRAMINGHAM HEART STUDY | 202141319349300914 |
| 2020 | The Glaucoma Foundation Inc | Duke University Charlotte, NC | A | $60,000 | paid | Medical Research | 202101689349301310 |
| 2019 | Alzheimer's Disease Research Foundation D/B/a Cure Alzheimer's Fund | Duke University School of Medicine Durham, NC | A | $91,687 | paid | A NOVEL APOE MIMETIC THERAPEUTIC PEPTIDE CN-105 ATTENUATES AD PATHOLOGY AND IMPROVES FUNCATIONAL OUTCOMES IN A MURINE MODEL OF AD | 202041559349301614 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are inferred and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF and Form 990 Schedule I e-file XML filed by the funders shown; this organization's identity from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The rows as Parquet: manifest.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.